Additionally, new non-peptide oral options like Orforglipron are actively in development
Numerous studies support the efficacy of GLP-1 agonists for weight loss both in patients with and without type 2 diabetes mellitus
They test four key characteristics that are associated with quality and safety
To a large extent, these changes are also characteristic of metabolic syndrome, which affects approximately 25% of the worlds adult population and is associated with insulin resistance, hypertension, dyslipidemia and obesity, factors that increasingly lead to cognitive impairment and brain atrophy
This isnt the only study to suggest there is a link between thyroid cancer and the use of this class of medications
Its also crucial to note that patients should exercise extreme caution in purchasing GLP-1 medications, as many do so online, which can result in misdosing and adverse side effects